FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/14/2025
Back to search
Official data from USPTO
PHARMETHEUS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
04/03/2026
Classification
Registered
Trademark type
Combined
Nice classes
9, 42, 44
Filing date
09/20/2022
Registration date
09/24/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/24/2024
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
99
Owner location
SE
Examiner
BLANDU, FLORENTINA
Law office
M80
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Pharmetheus AB
Representatives
Jolly-Johanna L. Northrop Holland & Hart LLP
Technical classification
Nice Classes
Class 9Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Downloadable computer software in the fields of pharmaceuticalsbiotechnologyhealthcarelife sciences for pharmaceutical research and development; downloadable computer software for providing medical and scientific research information in the field of pharmaceuticals and for analyzing and assessing the efficacy of pharmaceuticals
Class 42
Medical research; scientific research; providing medical and scientific research information; research and development in the pharmaceutical and biotechnology fields; providing medical and scientific research information in the field of pharmaceuticals; research on the subject of pharmaceuticals and interactions between pharmaceuticals and patients; services for assessing the efficacy of pharmaceuticalspharmaceutical research services relating to the assessment of the efficacy of pharmaceuticals; software as a service (SAAS) services featuring software for assessing the efficacy of pharmaceuticals; research in the field of pharmacologyphysiology and disease; research in the field of pharmacokinetics and pharmacodynamics; consultancy relating to research in the field of pharmacokinetics and pharmacodynamics; consultancy relating to pharmaceutical research and development; consultancy in the field of pharmaceutical research; pharmaceutical research and development; scientific analytical services in the field of pharmacokinetics and pharmacodynamics; consultancy relating to pharmacological analysis and research; design of mathematical models for the analysis of interactions between pharmaceuticals and patients; design of computer-simulated mathematical models; computer software development; software design and development; design and development of software in the field of mobile applications
Class 44
Medical services; medical analysis services relating to the treatment of patients; medical analysis services for diagnostic and treatment purposes; pharmaceutical servicesconsultancy and information services relating to pharmaceutical products; pharmaceutical advice; pharmaceutical analysis services
Publications
History of USPTO decisions and trademark events.
36 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/26/2025
FIMP
FINAL DISPOSITION PROCESSED
02/26/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/24/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/24/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
09/24/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/27/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/09/2024
PUBO
PUBLISHED FOR OPPOSITION
07/09/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/19/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/30/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
05/30/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/30/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
05/30/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/30/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
05/27/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/08/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
05/08/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/14/2024
GNRT
NON-FINAL ACTION E-MAILED
03/14/2024
CNRT
NON-FINAL ACTION WRITTEN
03/14/2024
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
02/29/2024
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
02/27/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/10/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/09/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/09/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/09/2024
RFNT
REFUSAL PROCESSED BY IB
08/29/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/09/2023
RFRR
REFUSAL PROCESSED BY MPU
08/09/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/05/2023
CNRT
NON-FINAL ACTION WRITTEN
07/04/2023
DOCK
ASSIGNED TO EXAMINER
06/30/2023
MAFR
APPLICATION FILING RECEIPT MAILED
12/13/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/09/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/08/2022
Continuous trademark protection
Get notified about every new filing that threatens PHARMETHEUS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.